照顾住院的新冠病毒肺炎患者：从炒作与希望到先做简单之事 - Suppr

Suppr

超能文献

Caring for Hospitalized COVID-19 Patients: From Hypes and Hopes to Doing the Simple Things First.

作者信息

Schultz Marcus J, Tun Ni Ni, Shrestha Gentle S

机构信息

Mahidol-Oxford Tropical Medicine Research Unit (MORU), Mahidol University, Bangkok, Thailand.

Amsterdam University Medical Centers, AMC, Amsterdam, The Netherlands.

出版信息

Am J Trop Med Hyg. 2021 Nov 1;106(3):751-753. doi: 10.4269/ajtmh.21-0961.

DOI:10.4269/ajtmh.21-0961

PMID:34724635

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8922481/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5804/8922481/efcb4102b19e/tpmd210961f1.jpg

相似文献

Caring for Hospitalized COVID-19 Patients: From Hypes and Hopes to Doing the Simple Things First.照顾住院的新冠病毒肺炎患者：从炒作与希望到先做简单之事

Am J Trop Med Hyg. 2021 Nov 1;106(3):751-753. doi: 10.4269/ajtmh.21-0961.

Leadership in a crisis: doing things differently, doing different things.危机中的领导力：以不同方式行事，做不同的事情。

Br J Hosp Med (Lond). 2020 Nov 2;81(11):1-9. doi: 10.12968/hmed.2020.0611. Epub 2020 Nov 17.

Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效：一项随机对照试验研究方案的结构化总结。

Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.

Casirivimab and Imdevimab Treatment Reduces Viral Load and Improves Clinical Outcomes in Seropositive Hospitalized COVID-19 Patients with Nonneutralizing or Borderline Neutralizing Antibodies.Casirivimab 和 Imdevimab 治疗可降低病毒载量并改善具有非中和或边缘中和抗体的血清阳性住院 COVID-19 患者的临床结局。

mBio. 2022 Dec 20;13(6):e0169922. doi: 10.1128/mbio.01699-22. Epub 2022 Oct 18.

Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.2021 年 7 月 15 日至 9 月 23 日和 2021 年 12 月 21 日至 2022 年 1 月 27 日期间，加利福尼亚州一家医院因实验室确诊的 SARS-CoV-2 感染住院的成年人的临床特征和结局，期间 B.1.617.2（德尔塔）和 B.1.1.529（奥密克戎）变异株占主导地位。

MMWR Morb Mortal Wkly Rep. 2022 Feb 11;71(6):217-223. doi: 10.15585/mmwr.mm7106e2.

Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial.评估人抗 SARS-CoV-2 恢复期血浆在 COVID-19 重症成人中的疗效和安全性：一项随机对照试验研究方案的结构化总结。

Trials. 2020 Jun 8;21(1):499. doi: 10.1186/s13063-020-04422-y.

SARS-CoV-2: Viral Loads of Exhaled Breath and Oronasopharyngeal Specimens in Hospitalized Patients with COVID-19.SARS-CoV-2：住院 COVID-19 患者呼出的呼吸和口咽标本中的病毒载量。

Int J Infect Dis. 2021 Sep;110:105-110. doi: 10.1016/j.ijid.2021.07.012. Epub 2021 Jul 7.

Post-COVID-19 Symptoms 2 Years After SARS-CoV-2 Infection Among Hospitalized vs Nonhospitalized Patients.SARS-CoV-2 感染后 2 年住院与非住院患者的新冠后症状。

JAMA Netw Open. 2022 Nov 1;5(11):e2242106. doi: 10.1001/jamanetworkopen.2022.42106.

[Pharmacological therapies against COVID-19 : state of the art, between hopes and disappointments].[针对新型冠状病毒肺炎的药物治疗：现状，希望与失望并存]

Rev Med Liege. 2020;75(S1):162-169.

Audio Interview: Caring for Hospitalized Patients with Covid-19.音频访谈：照顾新冠病毒肺炎住院患者

N Engl J Med. 2022 Nov 3;387(18):e51. doi: 10.1056/NEJMe2214245.

本文引用的文献

RETRACTED: Remdesivir Efficacy in COVID-19 Treatment: A Randomized Controlled Trial.撤回：瑞德西韦治疗 COVID-19 的疗效：一项随机对照试验。

Am J Trop Med Hyg. 2021 Sep 10;106(3):886-890. doi: 10.4269/ajtmh.21-0606.

Rational Use of Oxygen in COVID-19 Pandemic - Are We Doing Enough?新冠疫情期间氧气的合理使用——我们做得够吗？

JNMA J Nepal Med Assoc. 2021 Apr 30;59(236):429-431. doi: 10.31729/jnma.6479.

Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label meta-trial.清醒俯卧位治疗 COVID-19 急性低氧性呼吸衰竭：一项随机、对照、多中心、开放标签的荟萃分析。

Lancet Respir Med. 2021 Dec;9(12):1387-1395. doi: 10.1016/S2213-2600(21)00356-8. Epub 2021 Aug 20.

VTE Prophylaxis in Critically Ill Adults: A Systematic Review and Network Meta-analysis.危重症成人静脉血栓栓塞症预防：系统评价和网络荟萃分析。

Chest. 2022 Feb;161(2):418-428. doi: 10.1016/j.chest.2021.08.050. Epub 2021 Aug 19.

Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.新冠肺炎危重症患者的肝素治疗性抗凝。

N Engl J Med. 2021 Aug 26;385(9):777-789. doi: 10.1056/NEJMoa2103417. Epub 2021 Aug 4.

Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.COVID-19 非危重症患者的肝素治疗性抗凝。

N Engl J Med. 2021 Aug 26;385(9):790-802. doi: 10.1056/NEJMoa2105911. Epub 2021 Aug 4.

Higher incidence of arrhythmia in COVID-19 than in other community-acquired pneumonia: possible role of concurrent therapies.新型冠状病毒肺炎（COVID-19）患者心律失常的发生率高于其他社区获得性肺炎：联合治疗的潜在作用

Crit Care. 2021 Jul 22;25(1):259. doi: 10.1186/s13054-021-03655-w.

Difference between prolonged versus standard duration of prone position in COVID-19 patients: a retrospective study.COVID-19患者俯卧位延长与标准时长的差异：一项回顾性研究

Minerva Anestesiol. 2021 Dec;87(12):1383-1385. doi: 10.23736/S0375-9393.21.15864-X. Epub 2021 Jul 14.

Association of early positive end-expiratory pressure settings with ventilator-free days in patients with coronavirus disease 2019 acute respiratory distress syndrome: A secondary analysis of the Practice of VENTilation in COVID-19 study.新冠肺炎急性呼吸窘迫综合征患者早期呼气末正压设置与呼吸机使用天数的关系：COVID-19 通气实践研究的二次分析。

Eur J Anaesthesiol. 2021 Dec 1;38(12):1274-1283. doi: 10.1097/EJA.0000000000001565.

Battling COVID-19-related mortality: from a fight for ventilators to a cry for oxygen.抗击与新冠疫情相关的死亡：从争夺呼吸机到急需氧气

Lancet Respir Med. 2021 Sep;9(9):939-941. doi: 10.1016/S2213-2600(21)00267-8. Epub 2021 Jul 2.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验